MediPharm Labs Announces Change of Auditor

TORONTO, June 22, 2023 /PRNewswire/ – MediPharm Labs Corp. (TSX: LABS) (OTCQX:¬†MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that, at the request of the Company’s board of directors and following the recommendation of the audit committee, the Company’s board of directors have accepted the … Read more